Cannabis Clinical Trials Pharmaceutical Terpenes 
Project CBD
OCTOBER 26, 2023
Adapted from The Cannabis Cancer Connection: How to use cannabis and hemp to kill cancer cells by Joe D. The vast majority of the existing research is on how specific cannabinoids kill cancer, but a growing body of work is revealing how the entourage of compounds found in whole-plant cannabis kills cancer.
Veriheal
APRIL 11, 2022
Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the U.S. territories.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
NOVEMBER 11, 2023
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Puff Puff Post
JANUARY 13, 2020
However, cannabis has a multitude of other chemicals. These chemicals vary between different types of cannabis plants. Generally speaking, 99 cent stores sell CBD that doesn’t have its terpenes or other cannabinoids measured. Terpenes are the chemicals that give cannabis varieties their unique flavor or scent.
Puff Puff Post
JANUARY 13, 2020
However, cannabis has a multitude of other chemicals. These chemicals vary between different types of cannabis plants. Generally speaking, 99 cent stores sell CBD that doesn’t have its terpenes or other cannabinoids measured. Terpenes are the chemicals that give cannabis varieties their unique flavor or scent.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
NORML
SEPTEMBER 20, 2019
But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US. Later that night, everyone celebrated at a hotel bar.
Expert insights. Personalized for you.
343 
Let's personalize your content